The cancer diagnostics company’s share price dives after finally losing reimbursement of 60% of its US revenue.
Market Outlook: Fisher Funds chief investment officer Frank Jasper on the week ahead.
‘Those who do not remember the past are condemned to repeat it’ – Benjamin Graham.
Margin Call: Andrew Bascand explains how investing is about returns, not income.
The government backing is conditional on the fund hitting its $50m target.
Market Outlook: Fat Prophets head of research Greg Smith on the week ahead.
Secondary and primary markets experiencing a Covid-related gold rush.
Matt Whineray says the fund’s carbon exclusion policy has added returns.
Margin Call: Nicholas Bagnall explains the effects of differences in passive demand for different companies’ shares.
Market Outlook: Harbour Asset Management portfolio manager Shane Solly on the week ahead.